Sotagliflozin and decompensated heart failure: results of the SOLOIST-WHF trial

被引：9
|
作者：
Shah, Syed Raza [1 ]
Ali, Arroj [2 ]
Ikram, Sohail [3 ]
机构：
[1] Univ Louisville, Louisville, KY USA
[2] Lincoln Mem Univ, Coll Osteopath Med, Dept Med, Harrogate, TN USA
[3] FACC Univ Louisville, Dept Med, Louisville, KY USA
来源：
EXPERT REVIEW OF CLINICAL PHARMACOLOGY | 2021年 / 14卷 / 05期
关键词：
Sotagliflozin; heart failure; cardiovascular; SOLOIST-WHF trial;
D O I：
10.1080/17512433.2021.1908123
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：523 / 525
页数：3
相关论文
共 50 条
  • [1] Mediators of the benefit of sotagliflozin in patients with worsening heart failure in SOLOIST-WHF
    Szarek, M.
    Bhatt, D.
    Steg, P. G.
    Davies, M. J.
    Pitt, B.
    [J]. EUROPEAN HEART JOURNAL, 2023, 44
  • [2] TIME TO CLINICAL BENEFIT OF SOTAGLIFLOZIN IN PEOPLE WITH WORSENING HEART FAILURE IN SOLOIST-WHF
    Verma, Subodh
    Bhatt, Deepak L.
    Szarek, Michael
    Steg, Philippe Gabriel
    Pitt, Bertram
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 282 - 282
  • [3] Cost-Effectiveness of Sotagliflozin fl ozin in SOLOIST-WHF
    Weintraub, William S.
    Kolm, Paul
    Dolman, Sarahfaye
    Alva, Maria
    Bhatt, Deepak L.
    Zhang, Zugui
    [J]. JACC-HEART FAILURE, 2024, 12 (09) : 1600 - 1610
  • [4] Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events A Post Hoc Analysis of SOLOIST-WHF
    Pitt, Bertram
    Bhatt, Deepak L.
    Szarek, Michael
    Cannon, Christopher P.
    Leiter, Lawrence A.
    Mcguire, Darren K.
    Lewis, Julia B.
    Riddle, Matthew C.
    Voors, Adriaan A.
    Metra, Marco
    Lund, Lars H.
    Komajda, Michel
    Testani, Jeffrey M.
    Wilcox, Christopher S.
    Ponikowski, Piotr
    Lopes, Renato D.
    Ezekowitz, Justin A.
    Sun, Franklin
    Davies, Michael J.
    Verma, Subodh
    Kosiborod, Mikhail N.
    SOLOIST WHF Investigators
    [J]. JACC-HEART FAILURE, 2023, 11 (08) : 879 - 889
  • [5] Eligibility for sotagliflozin in a real-world heart failure population based on the SOLOIST-WHF trial enrolment criteria: data from the Swedish heart failure registry
    Becher, Peter Moritz
    Savarese, Gianluigi
    Benson, Lina
    Dahlstrom, Ulf
    Karlstrom, Patric
    Mol, Peter G. M.
    Metra, Marco
    Bhatt, Deepak L.
    Pitt, Bertram
    Lund, Lars H.
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2023, 9 (04) : 343 - 352
  • [6] Eligibility for sotagliflozin in a real-world heart failure population based on the SOLOIST-WHF trial enrolment criteria: data from the Swedish Heart Failure Registry
    Becher, P. M. Peter Moritz
    Savarese, G. S.
    Benson, L.
    Dahlstrom, U.
    Bhatt, D. L.
    Pitt, B.
    Lund, L. H.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 194 - 195
  • [7] SOTAGLIFLOZIN REDUCES TOTAL HOSPITALIZATIONS AND INCREASES DAYS ALIVE AND OUT OF HOSPITAL IN THE SOLOIST-WHF TRIAL
    Szarek, Michael
    Bhatt, Deepak
    Steg, Philippe Gabriel
    Cannon, Christopher
    Leiter, Lawrence
    McGuire, Darren
    Lewis, Julia
    Riddle, Matthew
    Voors, Adriaan
    Metra, Marco
    Lund, Lars
    Komajda, Michel
    Testani, Jeffrey
    Wilcox, Christopher
    Ponikowski, Piotr
    Lopes, Renato
    Banks, Phillip
    Tesfaye, Eshetu
    Ezekowitz, Justin
    Verma, Subodh
    Pitt, Bertram
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 519 - 519
  • [8] Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHF (vol 11, pg 879, 2023)
    Pitt, B.
    Bhatt, D. L.
    Szarek, M.
    Cannon, C. P.
    Leiter, L. A.
    Mcguire, D. K.
    Lewis, J. B.
    Riddle, M. C.
    Voors, A. A.
    Metra, M.
    Lund, L. H.
    Komajda, M.
    Testani, J. M.
    Wilcox, C. S.
    Ponikowki, P.
    Lopes, R. D.
    Ezekowitz, J. A.
    Sun, F.
    Davies, M. J.
    Verma, S.
    Kosiborod, M. N.
    Steg, P. G.
    [J]. JACC-HEART FAILURE, 2023, 11 (09)
  • [9] How Generalizable Is The Soloist-whf Trial In 'Real World' Patients With Diabetes Admitted With Heart Failure? Results From A Large Us Integrated Health System
    Canonico, Mario Enrico
    Hsia, Judith
    Szarek, Michael
    Cannon, Christopher P.
    Bonaca, Marc P.
    [J]. JOURNAL OF CARDIAC FAILURE, 2024, 30 (01) : 228 - 228
  • [10] The Effect of the Dual SGLT1 and 2 Inhibitor Sotagliflozin on Cardiovascular Mortality and Hospital Readmission Rates for Heart Failure at 30 and 90 Days Post Discharge in Patients With Type 2 Diabetes Hospitalized for Worsening Heart Failure in the SOLOIST-WHF Trial
    Pitt, Bertram
    Bhatt, Deepak L.
    Szarek, Michael
    Sun, Franklin
    Davies, Michael J.
    Steg, Philippe G.
    [J]. CIRCULATION, 2022, 146
12345